California’s recently enacted healthcare tax faces a potential roadblock as it requires approval from the federal government before taking effect. The tax, included in the 2026-27 state budget package signed by Governor Gavin Newsom, was passed without any Republican votes and aims to generate additional state revenue by imposing fees on commercial health plans, Medi-Cal managed care plans, and Obamacare plans.
The key component of the measure, Senate Bill 125, is an $8.85 per member, per month levy on private and public health insurers operating in California. This tax replaces a prior structure under which Medi-Cal plans were taxed at approximately $274 per member per month, while private plans were assessed a much lower fee of $2.25. The previous discrepancy enabled California to funnel federal matching Medicaid funds into the state’s Medi-Cal program. However, recent federal rules require states to tax all health plans equally, prompting the state to adopt the new, uniform fee.
Federal approval is necessary because the tax is designed to enhance federal Medicaid reimbursements by increasing the state’s share of Medi-Cal funding. The Centers for Medicare & Medicaid Services (CMS), currently led by Dr. Mehmet Oz, must review and authorize the state’s proposal under federal regulations.
Republican critics argue the tax shift unfairly burdens families with private health insurance, potentially increasing costs for working households. Assemblyman Carl DeMaio of San Diego characterized the measure as a disguised tax hike, estimating that it could raise healthcare expenses for California families by around $425 annually. Critics contend that health insurers are unlikely to absorb the tax without passing some or all of the costs onto consumers through higher premiums or other charges.
Supporters of the original tax framework, which voters approved via Proposition 35 in 2024, maintained that the tax was intended to bolster Medi-Cal services. However, opponents have described the tax mechanism as a financing strategy designed primarily to draw more federal Medicaid funds into the state budget, rather than a straightforward effort to improve healthcare access.
The fiscal pressures underpinning this debate stem from recent expansions of Medi-Cal benefits, including eligibility extensions to undocumented immigrants, which have increased program costs beyond initial projections. Instead of reducing spending or reforming the program, state leaders opted for revising the tax structure to maintain federal funding levels within the new regulatory environment.
This approach reflects broader tensions over California’s management of healthcare financing, as it relies increasingly on complex schemes to secure federal dollars rather than addressing the underlying cost growth in Medi-Cal directly. The fate of the healthcare tax now rests with the Trump administration, which holds the power to approve or reject the state’s tax under federal Medicaid policies.
As the debate continues, California’s healthcare funding strategy remains at a crossroads, balancing the competing priorities of expanding access, managing public program costs, and minimizing impacts on privately insured residents.